Bio-Device Licensing is a new report that assesses the critical success factors in drug/device collaborations, allowing both device and pharmaceutical companies to get the best out of these partnerships.

Bio-Device Licensing: Strategies for success will answer the following questions:

- What do interdisciplinary collaborations really mean for device, biotech and pharmaceutical companies?
- Where can synergies be found and what are the challenges?
- What are the next disruptive technologies?
- What are the emerging collaboration trends?
- What kind of partners are leading corporations seeking?
- How are valuable partnerships between large and small companies established?